Research library / Resveratrol and sirtuins

CC Small or few human trials. Promising, not proven. How we grade →RCT · 24 obese men

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition

M Poulsen, P Vestergaard, B Clasen, Y Radko, L Christensen, H Stødkilde-Jørgensen et al. Diabetes. 2013.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
1,500 mg of resveratrol a day for 4 weeks did not change insulin sensitivity on the clamp test (the primary outcome), glucose turnover, blood pressure, energy expenditure, liver or visceral fat, or inflammatory markers.
Limits
Small and short. Investigator-initiated, funded by Danish public agencies and foundations; no relevant conflicts reported.
Which of our grades it feeds
Source
doi.org/10.2337/db12-0975 · PubMed 23193181 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.